The neurotechnology startup Neurable, situated in Boston, Massachusetts, has raised $13 million.
Investors
- Pace Ventures
- TRAC
- Metaplanet
- Ultratech Capital Partners
Use of funds
The money will be utilized by the company to develop its platform, which will provide access to non-invasive BCI technology for businesses and original equipment manufacturers (OEMs), as well as broad consumer audience availability. In order to improve human performance, this entails broadening the company’s range of products, reference designs, algorithms, and enabled systems to include earphones, helmets, and other head-worn devices.
The business, which has generated more than $30 million since its establishment, is collaborating with its network of licensing partners to bring neurotechnology to life, one of the ways being through the impending release of the Neurable AI-powered MW75 Neuro headphones.
In order to test its technology and investigate potential applications for enhancing human performance, Neurable also collaborated with the 711 Human-Performance Wing of the Air Force Research Lab after completing Series A.
Building on this partnership, the business was awarded $5 million in contracts by the Department of Defense to continue developing this human technology in order to enhance the performance and health of soldiers.
About Neurable
Neurable is a neurotechnology business led by Dr. Ramses Alcaide, the CEO. The company specializes on developing AI-powered tools for brain-computer interface and brain signal translation. Its platform enables high-performance brain-computer interface in common products. It is driven by patented signal processing, developed via research across laboratories and universities, and enhanced by a scientific and professional product team.
